Parenteral Drugs (India) Limited with respect to announcement dated 02-Feb-2022, regarding appointment of Director and Company secretary in the Board meeting held on February 02, 2022. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment 2. Brief profile (in case of appointment) 3. Whether intimated in 24hrs 4. Affirmationﾠthat the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.? The response of the Company is awaited.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
